Our findings showed that the MGMT methylation status was significantly associated with the risk of GC (OR = 3.34, 95% CI = 2.34–4.76, P < 0.001), suggesting that MGMT methylation can be crucial for the carcinogenesis of gastric cancer. The gene discussed is MGMT; the disease is gastric cancer.